Compare · BNR vs MOH
BNR vs MOH
Side-by-side comparison of Burning Rock Biotech Limited (BNR) and Molina Healthcare Inc (MOH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BNR and MOH operate in Medical Specialities (Health Care), so they compete in similar markets.
- MOH is the larger of the two at $9.16B, about 41.1x BNR ($222.8M).
- Over the past year, BNR is up 636.5% and MOH is down 45.1% - BNR leads by 681.6 points.
- MOH has hit the wire 3 times in the past 4 weeks while BNR has been quiet.
- MOH has more recent analyst coverage (25 ratings vs 2 for BNR).
- Company
- Burning Rock Biotech Limited
- Molina Healthcare Inc
- Price
- $20.99+1.84%
- $175.91+0.84%
- Market cap
- $222.8M
- $9.16B
- 1M return
- -0.94%
- +25.82%
- 1Y return
- +636.49%
- -45.10%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2003
- News (4w)
- 0
- 3
- Recent ratings
- 2
- 25
Burning Rock Biotech Limited
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass IO, the corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. The company also offers LungCore for lung cancer, ProstrateCore for prostrate cancer, BreastCore for breast cancer, LymphPlasma for lymphomas, and ThyroCare for thyroid cancer. In addition, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. Burning Rock Biotech Limited has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, Sino Biopharm, CStone and BeiGene. The company was founded in 2014 and is headquartered in Guangzhou, China.
Molina Healthcare Inc
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. The company operates in two segments, Health Plans and Other. As of December 31, 2020, it served approximately 4.0 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 15 states. The company offers its health care services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies. Molina Healthcare, Inc. was founded in 1980 and is headquartered in Long Beach, California.
Latest BNR
- SEC Form 4 filed by Han Yusheng
- Burning Rock Announces Founder's Purchase of Its ADSs
- SEC Form 3 filed by new insider Deng Feng
- SEC Form 3 filed by new insider Hayes Wendy W.
- New insider Han Yusheng claimed ownership of 17,357,806 units of Ordinary Shares (SEC Form 3)
- New insider Zhang Zhihong claimed ownership of 1,061,990 units of Ordinary Shares (SEC Form 3)
- SEC Form 3 filed by new insider Hu Xiaozhi
- New insider Xu Licen Lisa claimed ownership of 22,718 units of Ordinary Shares (SEC Form 3)
- SEC Form 6-K filed by Burning Rock Biotech Limited
- Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
Latest MOH
- SEC Form 10-Q filed by Molina Healthcare Inc
- Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Molina Healthcare Reports First Quarter 2026 Financial Results
- SEC Form 4 filed by Grohowski Leo P
- SEC Form 4 filed by Lockhart Stephen H
- SEC Form 4 filed by Orlando Steven J
- SEC Form 4 filed by Wolf Dale B
- SEC Form 4 filed by Zoretic Richard C
- SEC Form 4 filed by Schapiro Richard M
- SEC Form 4 filed by Brasier Barbara L